CACLP 2024

On March 17, 2024, Nanjing Norland Biotechnology officially announced two significant products at the CACLP (China International Medical Equipment Expo): the CLIA+ Hematology Analyzer and the Integrated System of CLIA and Biochemistry.

CLIA+ Hematology Analyzer: CLIA (Chemiluminescence Immunoassay) is a highly sensitive and precise detection method. When combined with hematology analysis functionality, it can be applied widely in clinical settings, including disease diagnosis and treatment monitoring. This CLIA+ Hematology Analyzer is expected to provide more comprehensive patient information, aiding healthcare professionals in better understanding the health status of patients.

Integrated System of CLIA and Biochemistry: This integrated system combines CLIA technology with biochemical analysis technology, providing medical institutions with an integrated testing solution. By integrating both technologies, it can improve testing efficiency, reduce sample processing time, and provide more comprehensive testing results, assisting healthcare professionals in making more accurate diagnoses and treatment plans.

The release of these two products will contribute to the advancement of the clinical diagnostics field, enhancing the level of diagnosis and treatment and providing better medical services to patients.